Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cholinesterase Inhibitors
1.2.3 Memantine
1.2.4 Combination Drugs
1.3 Market by Application
1.3.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dementia and Alzheimer’s Disease Treatment Market Perspective (2018-2029)
2.2 Global Dementia and Alzheimer’s Disease Treatment Growth Trends by Region
2.2.1 Dementia and Alzheimer’s Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dementia and Alzheimer’s Disease Treatment Historic Market Size by Region (2018-2024)
2.2.3 Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Dementia and Alzheimer’s Disease Treatment Market Dynamics
2.3.1 Dementia and Alzheimer’s Disease Treatment Industry Trends
2.3.2 Dementia and Alzheimer’s Disease Treatment Market Drivers
2.3.3 Dementia and Alzheimer’s Disease Treatment Market Challenges
2.3.4 Dementia and Alzheimer’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Dementia and Alzheimer’s Disease Treatment by Players
3.1.1 Global Dementia and Alzheimer’s Disease Treatment Revenue by Players (2018-2024)
3.1.2 Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Dementia and Alzheimer’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Dementia and Alzheimer’s Disease Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Dementia and Alzheimer’s Disease Treatment Market Concentration Ratio
3.4.1 Global Dementia and Alzheimer’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dementia and Alzheimer’s Disease Treatment Revenue in 2022
3.5 Global Key Players of Dementia and Alzheimer’s Disease Treatment Head office and Area Served
3.6 Global Key Players of Dementia and Alzheimer’s Disease Treatment, Product and Application
3.7 Global Key Players of Dementia and Alzheimer’s Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dementia and Alzheimer’s Disease Treatment Breakdown Data by Type
4.1 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size by Type (2018-2024)
4.2 Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Dementia and Alzheimer’s Disease Treatment Breakdown Data by Application
5.1 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size by Application (2018-2024)
5.2 Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
6.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type
6.2.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024)
6.2.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2024-2029)
6.2.3 North America Dementia and Alzheimer’s Disease Treatment Market Share by Type (2018-2029)
6.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application
6.3.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024)
6.3.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2024-2029)
6.3.3 North America Dementia and Alzheimer’s Disease Treatment Market Share by Application (2018-2029)
6.4 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country
6.4.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2024)
6.4.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
7.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type
7.2.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024)
7.2.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2024-2029)
7.2.3 Europe Dementia and Alzheimer’s Disease Treatment Market Share by Type (2018-2029)
7.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application
7.3.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024)
7.3.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2024-2029)
7.3.3 Europe Dementia and Alzheimer’s Disease Treatment Market Share by Application (2018-2029)
7.4 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country
7.4.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2024)
7.4.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
8.2 China Dementia and Alzheimer’s Disease Treatment Market Size by Type
8.2.1 China Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024)
8.2.2 China Dementia and Alzheimer’s Disease Treatment Market Size by Type (2024-2029)
8.2.3 China Dementia and Alzheimer’s Disease Treatment Market Share by Type (2018-2029)
8.3 China Dementia and Alzheimer’s Disease Treatment Market Size by Application
8.3.1 China Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024)
8.3.2 China Dementia and Alzheimer’s Disease Treatment Market Size by Application (2024-2029)
8.3.3 China Dementia and Alzheimer’s Disease Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
9.2 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Type
9.2.1 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024)
9.2.2 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Type (2024-2029)
9.2.3 Asia Dementia and Alzheimer’s Disease Treatment Market Share by Type (2018-2029)
9.3 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Application
9.3.1 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024)
9.3.2 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Application (2024-2029)
9.3.3 Asia Dementia and Alzheimer’s Disease Treatment Market Share by Application (2018-2029)
9.4 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Region
9.4.1 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Region (2018-2024)
9.4.3 Asia Dementia and Alzheimer’s Disease Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Dementia and Alzheimer’s Disease Treatment Introduction
11.1.4 Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
11.1.5 Novartis Recent Developments
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Details
11.2.2 Pfizer, Inc. Business Overview
11.2.3 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Introduction
11.2.4 Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
11.2.5 Pfizer, Inc. Recent Developments
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Details
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Introduction
11.3.4 AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
11.3.5 AbbVie Inc. Recent Developments
11.4 Allergan plc
11.4.1 Allergan plc Company Details
11.4.2 Allergan plc Business Overview
11.4.3 Allergan plc Dementia and Alzheimer’s Disease Treatment Introduction
11.4.4 Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
11.4.5 Allergan plc Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Introduction
11.5.4 Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
11.5.5 Eli Lilly and Company Recent Developments
11.6 F. Hoffmann-La Roche Ltd.
11.6.1 F. Hoffmann-La Roche Ltd. Company Details
11.6.2 F. Hoffmann-La Roche Ltd. Business Overview
11.6.3 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Introduction
11.6.4 F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
11.6.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Dementia and Alzheimer’s Disease Treatment Introduction
11.7.4 AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
11.7.5 AstraZeneca Recent Developments
11.8 Biogen
11.8.1 Biogen Company Details
11.8.2 Biogen Business Overview
11.8.3 Biogen Dementia and Alzheimer’s Disease Treatment Introduction
11.8.4 Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
11.8.5 Biogen Recent Developments
11.9 Eisai Co., Ltd.
11.9.1 Eisai Co., Ltd. Company Details
11.9.2 Eisai Co., Ltd. Business Overview
11.9.3 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Introduction
11.9.4 Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
11.9.5 Eisai Co., Ltd. Recent Developments
11.10 INmuneBIO
11.10.1 INmuneBIO Company Details
11.10.2 INmuneBIO Business Overview
11.10.3 INmuneBIO Dementia and Alzheimer’s Disease Treatment Introduction
11.10.4 INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
11.10.5 INmuneBIO Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Cholinesterase Inhibitors
Table 3. Key Players of Memantine
Table 4. Key Players of Combination Drugs
Table 5. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region (2018-2024)
Table 9. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region (2024-2029)
Table 11. Dementia and Alzheimer’s Disease Treatment Market Trends
Table 12. Dementia and Alzheimer’s Disease Treatment Market Drivers
Table 13. Dementia and Alzheimer’s Disease Treatment Market Challenges
Table 14. Dementia and Alzheimer’s Disease Treatment Market Restraints
Table 15. Global Dementia and Alzheimer’s Disease Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Dementia and Alzheimer’s Disease Treatment Revenue Share by Players (2018-2024)
Table 17. Global Top Dementia and Alzheimer’s Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2022)
Table 18. Global Dementia and Alzheimer’s Disease Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Dementia and Alzheimer’s Disease Treatment, Headquarters and Area Served
Table 21. Global Key Players of Dementia and Alzheimer’s Disease Treatment, Product and Application
Table 22. Global Key Players of Dementia and Alzheimer’s Disease Treatment, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2018-2024)
Table 26. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Dementia and Alzheimer’s Disease Treatment Revenue Share by Application (2018-2024)
Table 30. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Dementia and Alzheimer’s Disease Treatment Revenue Share by Application (2024-2029)
Table 32. North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Dementia and Alzheimer’s Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Dementia and Alzheimer’s Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Dementia and Alzheimer’s Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Dementia and Alzheimer’s Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Dementia and Alzheimer’s Disease Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Dementia and Alzheimer’s Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis Dementia and Alzheimer’s Disease Treatment Product
Table 67. Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024) & (US$ Million)
Table 68. Novartis Recent Developments
Table 69. Pfizer, Inc. Company Details
Table 70. Pfizer, Inc. Business Overview
Table 71. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product
Table 72. Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024) & (US$ Million)
Table 73. Pfizer, Inc. Recent Developments
Table 74. AbbVie Inc. Company Details
Table 75. AbbVie Inc. Business Overview
Table 76. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product
Table 77. AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024) & (US$ Million)
Table 78. AbbVie Inc. Recent Developments
Table 79. Allergan plc Company Details
Table 80. Allergan plc Business Overview
Table 81. Allergan plc Dementia and Alzheimer’s Disease Treatment Product
Table 82. Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024) & (US$ Million)
Table 83. Allergan plc Recent Developments
Table 84. Eli Lilly and Company Company Details
Table 85. Eli Lilly and Company Business Overview
Table 86. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product
Table 87. Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024) & (US$ Million)
Table 88. Eli Lilly and Company Recent Developments
Table 89. F. Hoffmann-La Roche Ltd. Company Details
Table 90. F. Hoffmann-La Roche Ltd. Business Overview
Table 91. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product
Table 92. F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024) & (US$ Million)
Table 93. F. Hoffmann-La Roche Ltd. Recent Developments
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca Dementia and Alzheimer’s Disease Treatment Product
Table 97. AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024) & (US$ Million)
Table 98. AstraZeneca Recent Developments
Table 99. Biogen Company Details
Table 100. Biogen Business Overview
Table 101. Biogen Dementia and Alzheimer’s Disease Treatment Product
Table 102. Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024) & (US$ Million)
Table 103. Biogen Recent Developments
Table 104. Eisai Co., Ltd. Company Details
Table 105. Eisai Co., Ltd. Business Overview
Table 106. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product
Table 107. Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024) & (US$ Million)
Table 108. Eisai Co., Ltd. Recent Developments
Table 109. INmuneBIO Company Details
Table 110. INmuneBIO Business Overview
Table 111. INmuneBIO Dementia and Alzheimer’s Disease Treatment Product
Table 112. INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2018-2024) & (US$ Million)
Table 113. INmuneBIO Recent Developments
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Dementia and Alzheimer’s Disease Treatment Market Share by Type: 2022 VS 2029
Figure 3. Cholinesterase Inhibitors Features
Figure 4. Memantine Features
Figure 5. Combination Drugs Features
Figure 6. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Dementia and Alzheimer’s Disease Treatment Report Years Considered
Figure 11. Global Dementia and Alzheimer’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Dementia and Alzheimer’s Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players in 2022
Figure 15. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue in 2022
Figure 17. North America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Dementia and Alzheimer’s Disease Treatment Market Share by Type (2018-2029)
Figure 19. North America Dementia and Alzheimer’s Disease Treatment Market Share by Application (2018-2029)
Figure 20. North America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 21. United States Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Dementia and Alzheimer’s Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Type (2018-2029)
Figure 25. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Application (2018-2029)
Figure 26. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 27. Germany Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Dementia and Alzheimer’s Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Dementia and Alzheimer’s Disease Treatment Market Share by Type (2018-2029)
Figure 35. China Dementia and Alzheimer’s Disease Treatment Market Share by Application (2018-2029)
Figure 36. Asia Dementia and Alzheimer’s Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Dementia and Alzheimer’s Disease Treatment Market Share by Type (2018-2029)
Figure 38. Asia Dementia and Alzheimer’s Disease Treatment Market Share by Application (2018-2029)
Figure 39. Asia Dementia and Alzheimer’s Disease Treatment Market Share by Region (2018-2029)
Figure 40. Japan Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2018-2029)
Figure 50. Brazil Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Novartis Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
Figure 57. Pfizer, Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
Figure 58. AbbVie Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
Figure 59. Allergan plc Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
Figure 61. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
Figure 62. AstraZeneca Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
Figure 63. Biogen Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
Figure 64. Eisai Co., Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
Figure 65. INmuneBIO Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2018-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed